Previous work also compared mutations found in plasma and in tumor samples from NSCLC patients, and additional mutations were found in ctDNA analysis in several genes: EGFR, KRAS, PIK3CA, and TP53 (18). Here, EGFR is linked to non-small cell lung carcinoma.